- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-511X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Sphingolipids in cardiovascular diseases and metabolic disorders ; volume:14 ; number:1 ; day:16 ; month:6 ; year:2015 ; pages:1-8 ; date:12.2015
Lipids in health and disease ; 14, Heft 1 (16.6.2015), 1-8, 12.2015
- Creator
-
Borodzicz, Sonia
Czarzasta, Katarzyna
Kuch, Marek
Cudnoch-Jedrzejewska, Agnieszka
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12944-015-0053-y
- URN
-
urn:nbn:de:101:1-2021080720572926330400
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
2025-08-14T10:55:58+0200
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Borodzicz, Sonia
- Czarzasta, Katarzyna
- Kuch, Marek
- Cudnoch-Jedrzejewska, Agnieszka
- SpringerLink (Online service)
Other Objects (12)
Inherited disorders, metabolic disorders and rare diseases
Metabolic disorders and risk of cardiovascular diseases: a two-sample mendelian randomization study
Endocrine-metabolic markers and subclinical cardiovascular disorders
Endocrine-metabolic markers and subclinical cardiovascular disorders
Implication of gut microbiota metabolites in cardiovascular and metabolic diseases
Role of circulating molecules in age-related cardiovascular and metabolic disorders
Mechanisms of Action of Kefir in Chronic Cardiovascular and Metabolic Diseases
Hydrogen Therapy in Cardiovascular and Metabolic Diseases: from Bench to Bedside
Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases
Cardiovascular diseases
Cardiovascular diseases
Ferroptosis-based advanced therapies as treatment approaches for metabolic and cardiovascular diseases
Inherited disorders, metabolic disorders and rare diseases
Metabolic disorders and risk of cardiovascular diseases: a two-sample mendelian randomization study
Endocrine-metabolic markers and subclinical cardiovascular disorders
Endocrine-metabolic markers and subclinical cardiovascular disorders
Implication of gut microbiota metabolites in cardiovascular and metabolic diseases
Role of circulating molecules in age-related cardiovascular and metabolic disorders
Mechanisms of Action of Kefir in Chronic Cardiovascular and Metabolic Diseases
Hydrogen Therapy in Cardiovascular and Metabolic Diseases: from Bench to Bedside
Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases
Cardiovascular diseases
Cardiovascular diseases
Ferroptosis-based advanced therapies as treatment approaches for metabolic and cardiovascular diseases
Inherited disorders, metabolic disorders and rare diseases
Metabolic disorders and risk of cardiovascular diseases: a two-sample mendelian randomization study
Endocrine-metabolic markers and subclinical cardiovascular disorders
Endocrine-metabolic markers and subclinical cardiovascular disorders
Implication of gut microbiota metabolites in cardiovascular and metabolic diseases
Role of circulating molecules in age-related cardiovascular and metabolic disorders
Mechanisms of Action of Kefir in Chronic Cardiovascular and Metabolic Diseases
Hydrogen Therapy in Cardiovascular and Metabolic Diseases: from Bench to Bedside
Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases
Cardiovascular diseases
Cardiovascular diseases